RIA
GSK icon

Regal Investment Advisors’s GSK GSK Stock Holding History

Regal Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$454K Buy
8,222
+942
+13% +$51K 0.03% 453
2025
Q4 		$357K Sell
7,280
-42
-0.6% -$1.96K 0.02% 481
2025
Q3 		$316K Buy
7,322
+21
+0.3% +$820 0.02% 458
2025
Q2 		$280K Sell
7,301
-1,373
-16% -$52.5K 0.02% 436
2025
Q1 		$336K Buy
8,674
+171
+2% +$6.26K 0.03% 380
2024
Q4 		$288K Buy
8,503
+597
+8% +$21.5K 0.02% 414
2024
Q3 		$323K Sell
7,906
-48
-0.6% -$1.96K 0.02% 435
2024
Q2 		$306K Sell
7,954
-15,922
-67% -$670K 0.02% 456
2024
Q1 		$1.02M Buy
23,876
+159
+0.7% +$6.56K 0.07% 240
2023
Q4 		$879K Sell
23,717
-1,603
-6% -$57.5K 0.07% 244
2023
Q3 		$918K Sell
25,320
-1,034
-4% -$36.7K 0.08% 220
2023
Q2 		$939K Buy
26,354
+348
+1% +$12.5K 0.08% 211
2023
Q1 		$925K Sell
26,006
-1,591
-6% -$55.7K 0.08% 204
2022
Q4 		$970K Buy
27,597
+3,443
+14% +$115K 0.09% 194
2022
Q3 		$711K Buy
24,154
+15,559
+181% +$590K 0.08% 218
2022
Q2 		$468K Sell
8,595
-487
-5% -$26.9K 0.05% 292
2022
Q1 		$494K Sell
9,082
-1,458
-14% -$79.2K 0.05% 310
2021
Q4 		$581K Sell
10,540
-538
-5% -$28K 0.05% 311
2021
Q3 		$529K Buy
11,078
+1,170
+12% +$58.8K 0.05% 324
2021
Q2 		$493K Buy
+9,908
New +$476K 0.05% 332
2021
Q1 		– Sell
-19,205
Closed -$883K – 197
2020
Q4 		$883K Buy
+19,205
New +$882K 0.1% 195
2020
Q3 		– Sell
-16,817
Closed -$857K – 102
2020
Q2 		$857K Buy
+16,817
New +$863K 0.16% 133
2020
Q1 		– Sell
-12,193
Closed -$716K – 142
2019
Q4 		$716K Buy
12,193
+281
+2% +$15.6K 0.13% 162
2019
Q3 		$635K Buy
11,912
+1,575
+15% +$81K 0.12% 166
2019
Q2 		$517K Buy
10,337
+86
+0.8% +$4.32K 0.1% 188
2019
Q1 		$535K Buy
10,251
+3,000
+41% +$150K 0.11% 179
2018
Q4 		$346K Buy
+7,251
New +$357K 0.08% 222
2016
Q4 		– Sell
-3,953
Closed -$213K – 256
2016
Q3 		$213K Buy
+3,953
New +$217K 0.06% 245
2016
Q1 		– Sell
-5,263
Closed -$265K – 265
2015
Q4 		$265K Buy
5,263
+321
+6% +$16.4K 0.07% 213
2015
Q3 		$237K Buy
4,942
+3,586
+264% +$187K 0.06% 214
2015
Q2 		$70K Buy
1,356
+256
+23% +$14.4K 0.02% 381
2015
Q1 		$63K Sell
1,100
-50
-4% -$2.87K 0.02% 398
2014
Q4 		$61K Sell
1,150
-535
-32% -$29.9K 0.02% 374
2014
Q3 		$97K Buy
1,685
+1,347
+399% +$82.6K 0.03% 306
2014
Q2 		$23K Buy
338
+68
+25% +$4.6K 0.01% 519
2014
Q1 		$18K Buy
270
+79
+41% +$5.34K 0.01% 534
2013
Q4 		$13K Sell
191
-279
-59% -$18.1K 0.01% 540
2013
Q3 		$30K Sell
470
-276
-37% -$17.8K 0.02% 392
2013
Q2 		$47K Buy
+746
New +$47.3K 0.03% 299

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Regal Investment Advisors's GSK Position: Q1 2026 in Review

Regal Investment Advisors increased its GSK (GSK) stake by 13% in Q1 2026, buying an estimated $51K and bringing the position to 8,222 shares worth $454K. The position accounts for 0.03% of the portfolio, ranked #453.

Regal Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.02M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Regal Investment Advisors held 8,222 shares of GSK worth $454K as of Q1 2026.
  • Regal Investment Advisors bought 942 GSK shares in Q1 2026, an estimated $51K.
  • GSK made up 0.03% of Regal Investment Advisors's portfolio in Q1 2026, its #453 holding.
  • Regal Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 39 quarters since.
  • Regal Investment Advisors's GSK position peaked at $1.02M in Q1 2024.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.